Status:

COMPLETED

The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease

Lead Sponsor:

Oregon State University

Collaborating Sponsors:

Oregon Health and Science University

National Center for Complementary and Integrative Health (NCCIH)

Conditions:

Atherosclerosis

Eligibility:

All Genders

50-70 years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to see if a dietary supplement, R-alpha lipoic acid, is able to reduce risk factors in people with documented heart disease and increased levels of inflammation.

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Documented congestive heart disease (CHD)(defined as at least one significant coronary stenosis \> 50% on angiography, or history of documented myocardial infarction)
  • Not diagnosed with unstable angina, uncontrolled hypertension, heart failure, recent myocardial infarction (within last six months)
  • Not taking insulin or oral hypoglycemic agents, anti-inflammatory drugs other than aspirin, or hormone replacement therapy
  • On stable doses for four weeks prior to entry of lipid-lowering therapy (statins), aspirin, and angiotensin-converting enzyme inhibitors or other blood pressure medications. P
  • No tobacco use within 3 months of the study
  • No laboratory evidence of renal, hepatic, or hematological abnormalities
  • Not currently taking vitamin or antioxidant supplements, including R-alpha lipoic acid, except standard multivitamin/mineral supplements containing not more than the Daily Value (DV) of the vitamins and minerals;
  • Elevated levels of urinary and plasma F2-isoprostanes
  • Elevated plasma levels of hs-CRP

Exclusion

    Key Trial Info

    Start Date :

    August 1 2011

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2024

    Estimated Enrollment :

    28 Patients enrolled

    Trial Details

    Trial ID

    NCT00764270

    Start Date

    August 1 2011

    End Date

    October 1 2024

    Last Update

    April 11 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Oregon Health & Science University

    Portland, Oregon, United States, 97201